Gevo, Inc. (GEVO) Misses Q4 EPS by 5c
Get Alerts GEVO Hot Sheet
Join SI Premium – FREE
Gevo, Inc. (NASDAQ: GEVO) reported Q4 EPS of ($0.54), $0.05 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $17 million.
For earnings history and earnings-related data on Gevo, Inc. (GEVO) click here.
For earnings history and earnings-related data on Gevo, Inc. (GEVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- MoonLake Immunotherapeutics (MLTX) Misses Q3 EPS by 15c
- Seres Therapeutics (MCRB) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share